In search of small molecules blocking interactions between HIV proteins and intracellular cofactors.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Molecular Biosystems

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1039/b810306bPMID 19081927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibitory profile of a LEDGF/p75 peptide against HIV‐1 integrase: Insight into integrase–DNA complex formation and catalysis

  2008cited by this paper
• Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

  2008cited by this paper
• Raltegravir: an integrase inhibitor for HIV-1

  2008cited by this paper
• Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition

  2008cited by this paper
• Identification of Host Proteins Required for HIV Infection Through a Functional Genomic Screen

  2008cited by this paper
• The cyclophilin inhibitor Debio‐025 shows potent anti–hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus

  2008cited by this paper
• Small Molecule Inhibitors Targeting HIV‐1 Reverse Transcriptase Dimerization

  2008cited by this paper
• Host factors exploited by retroviruses

  2007cited by this paper
• Cyclophilin inhibitors in hepatitis C viral infection

  2007cited by this paper
• Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.

  2007cited by this paper
• Structure-based mutagenesis of the integrase-LEDGF/p75 interface uncouples a strict correlation between in vitro protein binding and HIV-1 fitness.

  2007cited by this paper
• Identification of novel therapeutic targets for HIV infection through functional genomic cDNA screening.

  2007cited by this paper
• Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting

  2007cited by this paper
• Blocking interactions between HIV-1 integrase and cellular cofactors: an emerging anti-retroviral strategy.

  2007cited by this paper
• Reaching for high-hanging fruit in drug discovery at protein–protein interfaces

  2007cited by this paper
• LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration.

  2007cited by this paper
• Chromatinized templates reveal the requirement for the LEDGF/p75 PWWP domain during HIV-1 integration in vitro

  2007cited by this paper
• Antibody cocktails: next-generation biopharmaceuticals with improved potency.

  2007cited by this paper
• Inhibiting HIV-1 integrase by shifting its oligomerization equilibrium

  2007cited by this paper
• Identification of the LEDGF/p75 binding site in HIV-1 integrase.

  2007cited by this paper
• Virus Evolution Reveals an Exclusive Role for LEDGF/p75 in Chromosomal Tethering of HIV

  2007cited by this paper
• MDM2 inhibitors for cancer therapy.

  2007cited by this paper
• Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.

  2006cited by this paper
• Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivo

  2006cited by this paper
• Cellular co-factors of HIV-1 integration.

  2006cited by this paper
• Transient and Stable Knockdown of the Integrase Cofactor LEDGF/p75 Reveals Its Role in the Replication Cycle of Human Immunodeficiency Virus

  2006cited by this paper
• Overexpression of the Lens Epithelium-Derived Growth Factor/p75 Integrase Binding Domain Inhibits Human Immunodeficiency Virus Replication

  2006cited by this paper
• Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions

  2006cited by this paper
• Hot-spot mimicry of a cytokine receptor by a small molecule

  2006cited by this paper
• Wild-Type Levels of Human Immunodeficiency Virus Type 1 Infectivity in the Absence of Cellular Emerin Protein

  2006cited by this paper
• A small-molecule inhibitor of Bcl-XL potentiates the activity of cytotoxic drugs in vitro and in vivo.

  2006cited by this paper
• “UnPAKing” Human Immunodeficiency Virus (HIV) Replication: Using Small Interfering RNA Screening To Identify Novel Cofactors and Elucidate the Role of Group I PAKs in HIV Infection

  2006cited by this paper
• Identification and characterization of the chromatin-binding domains of the HIV-1 integrase interactor LEDGF/p75.

  2006cited by this paper
• NIM811, a Cyclophilin Inhibitor, Exhibits Potent In Vitro Activity against Hepatitis C Virus Alone or in Combination with Alpha Interferon

  2006cited by this paper
• Transcriptional co-activator p75 binds and tethers the Myc-interacting protein JPO2 to chromatin

  2006cited by this paper
• Identification of a Novel Human Immunodeficiency Virus Type 1 Integrase Interactor, Gemin2, That Facilitates Efficient Viral cDNA Synthesis In Vivo

  2006cited by this paper
• An Essential Role for LEDGF/p75 in HIV Integration

  2006cited by this paper
• A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo

  2006cited by this paper
• Identification of nonpeptidic small-molecule inhibitors of interleukin-2.

  2005cited by this paper
• An inhibitor of Bcl-2 family proteins induces regression of solid tumours

  2005cited by this paper
• A role for LEDGF/p75 in targeting HIV DNA integration

  2005cited by this paper
• Structural Details on mdm2-p53 Interaction*

  2005cited by this paper
• Solution structure of the HIV-1 integrase-binding domain in LEDGF/p75

  2005cited by this paper
• Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75.

  2005cited by this paper
• Inhibiting protein-protein interactions using designed molecules.

  2005cited by this paper
• Integrase Mutants Defective for Interaction with LEDGF/p75 Are Impaired in Chromosome Tethering and HIV-1 Replication*

  2005cited by this paper
• Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.

  2005cited by this paper
• Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

  2005cited by this paper
• Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering

  2005cited by this paper
• Protein-protein interactions in human disease.

  2005cited by this paper
• Discovery and cocrystal structure of benzodiazepinedione HDM2 antagonists that activate p53 in cells.

  2005cited by this paper
• 1,4-Benzodiazepine-2,5-diones as small molecule antagonists of the HDM2-p53 interaction: discovery and SAR.

  2005cited by this paper
• Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

  2004cited by this paper
• Identification and Characterization of a Functional Nuclear Localization Signal in the HIV-1 Integrase Interactor LEDGF/p75*

  2004cited by this paper
• Crystal Structure of the E2 Transactivation Domain of Human Papillomavirus Type 11 Bound to a Protein Interaction Inhibitor*

  2004cited by this paper
• Emerging classes of protein-protein interaction inhibitors and new tools for their development.

  2004cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Identification of an Evolutionarily Conserved Domain in Human Lens Epithelium-derived Growth Factor/Transcriptional Co-activator p75 (LEDGF/p75) That Binds HIV-1 Integrase*

  2004cited by this paper
• Fragment-based drug discovery.

  2004cited by this paper
• LEDGF/p75 Determines Cellular Trafficking of Diverse Lentiviral but Not Murine Oncoretroviral Integrase Proteins and Is a Component of Functional Lentiviral Preintegration Complexes

  2004cited by this paper
• Protein‐protein interactions as a target for drugs in proteomics

  2003cited by this paper
• The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif

  2003cited by this paper
• Targeting of the Human Immunodeficiency Virus Type 1 Envelope to the trans-Golgi Network through Binding to TIP47 Is Required for Env Incorporation into Virions and Infectivity

  2003cited by this paper
• Discovery of the first series of inhibitors of human papillomavirus type 11: inhibition of the assembly of the E1-E2-Origin DNA complex.

  2003cited by this paper
• Binding of small molecules to an adaptive protein–protein interface

  2003cited by this paper
• Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts

  2003cited by this paper
• Inhibition of Human Papillomavirus DNA Replication by Small Molecule Antagonists of the E1-E2 Protein Interaction*

  2003cited by this paper
• Hypermutation of HIV-1 DNA in the Absence of the Vif Protein

  2003cited by this paper
• Discovery of a potent small molecule IL-2 inhibitor through fragment assembly.

  2003cited by this paper
• LEDGF/p75 Is Essential for Nuclear and Chromosomal Targeting of HIV-1 Integrase in Human Cells*

  2003cited by this paper
• Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function

  2002cited by this paper
• Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its pro-survival function: implications for autoimmunity in atopic disorders

  2002cited by this paper
• New biarsenical ligands and tetracysteine motifs for protein labeling in vitro and in vivo: synthesis and biological applications.

  2002cited by this paper
• Faculty Opinions recommendation of Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

  2002cited by this paper
• Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein

  2002cited by this paper
• Unraveling hot spots in binding interfaces: progress and challenges.

  2002cited by this paper
• LEDGF, a survival factor, activates stress-related genes.

  2002cited by this paper
• Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding.

  2001cited by this paper
• Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain.

  2001cited by this paper
• Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag

  2001cited by this paper
• HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress

  2001cited by this paper
• A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines.

  2000cited by this paper
• Lens epithelium-derived growth factor (LEDGF/p75) and p52 are derived from a single gene by alternative splicing.

  2000cited by this paper
• HIV-1 integrase: structural organization, conformational changes, and catalysis.

  1999cited by this paper
• Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation

  1998cited by this paper
• Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A.

  1998cited by this paper
• Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

  1998cited by this paper
• Biology of the interleukin-2 receptor.

  1998cited by this paper
• Identification of a Small Molecule Inhibitor of the IL-2/IL-2Rα Receptor Interaction Which Binds to IL-2

  1997cited by this paper
• Principles of protein-protein interactions.

  1996cited by this paper
• Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

  1996cited by this paper
• Interacting Residues in the Extracellular Region of the Common β Subunit of the Human Granulocyte-Macrophage Colony-stimulating Factor, Interleukin (IL)-3, and IL-5 Receptors Involved in Constitutive Activation*

  1996cited by this paper
• A Soluble Active Mutant of HIV-1 Integrase

  1996cited by this paper
• Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction.

  1996cited by this paper
• Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A.

  1995cited by this paper
• Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5.

  1994cited by this paper
• Rous sarcoma virus integrase protein: mapping functions for catalysis and substrate binding

  1994cited by this paper
• Identification of discrete functional domains of HIV‐1 integrase and their organization within an active multimeric complex.

  1993cited by this paper
• Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro

  1992cited by this paper
• Edinburgh Research Explorer Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations

  year unknowncited by this paper

• Effective natural food complements: anti-CoV-2 spike protein directed druggable inhibitors

  2020cites this paper
• Extracting functional groups of ALLINI to design derivatives of FDA‐approved drugs: Inhibition of HIV‐1 integrase

  2018cites this paper
• LEDGF/p75: revisão sobre relação com doenças e interação com o sistema imunológico

  2016cites this paper
• Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends.

  2016cites this paper
• Targeting Virus-host Interactions of HIV Replication.

  2015cites this paper
• Recent Advances in the Development of Small-Molecular Inhibitors Target HIV Integrase-LEDGF/p75 Interaction.

  2015cites this paper
• 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.

  2014cites this paper
• Molecular Modeling Study on the Allosteric Inhibition Mechanism of HIV-1 Integrase by LEDGF/p75 Binding Site Inhibitors

  2014cites this paper
• A combination HIV reporter virus system for measuring post-entry event efficiency and viral outcome in primary CD4+ T cell subsets.

  2014cites this paper
• HIV-1 integrase binding to its cellular partners: a perspective from computational biology.

  2014cites this paper
• Network-based strategies can help mono- and poly-pharmacology drug discovery: a systems biology view.

  2014cites this paper
• Cellular Cofactors of HIV as Drug Targets

  2014cites this paper
• Improved assays for determining the cytosolic access of peptides, proteins, and their mimetics.

  2013cites this paper
• Identifying Chemicals with Potential Therapy of HIV Based on Protein-Protein and Protein-Chemical Interaction Network

  2013influential citation
• Rational design of LEDGINs as first allosteric integrase inhibitors for the treatment of HIV infection.

  2013cites this paper
• Discovery of small molecule HIV-1 integrase dimerization inhibitors.

  2012cites this paper
• Expanding the conformational selection paradigm in protein-ligand docking.

  2012cites this paper
• Phage display-directed discovery of LEDGF/p75 binding cyclic peptide inhibitors of HIV replication.

  2012cites this paper
• Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery

  2012cites this paper
• Allosteric Inhibitor Development Targeting HIV‐1 Integrase

  2011cites this paper
• Molecular Crosstalk between HIV-1 Integration and Host Proteins – Implications for Therapeutics

  2011cites this paper
• Modulators of protein-protein interactions: novel approaches in targeting protein kinases and other pharmaceutically relevant biomolecules.

  2011cites this paper
• New first and second generation inhibitors of human immunodeficiency virus-1 integrase

  2011cites this paper
• Inhibition of the interaction between HIV-1 integrase and its cofactor LEDGF/p75: a promising approach in anti-retroviral therapy.

  2011cites this paper
• The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

  2011cites this paper
• Non-amyloid Approaches To Alzheimer's Disease

  2010cites this paper
• Targeting protein-protein interactions: a promising avenue of anti-HIV drug discovery.

  2010cites this paper
• Reversible, Allosteric Small-Molecule Inhibitors of Regulator of G Protein Signaling Proteins

  2010cites this paper
• The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures

  2010cites this paper
• Crystal structure of the HIV‐1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site

  2010cites this paper
• Blocking nuclear import of pre-integration complex: an emerging anti-HIV-1 drug discovery paradigm.

  2010cites this paper
• Small molecules targeting protein-protein interactions: A promising anti-HIV strategy

  2010cites this paper
• Development and validation of a high throughput screening system for inhibitors of HIV infection

  2009cites this paper
• Virological and cellular roles of the transcriptional coactivator LEDGF/p75.

  2009cites this paper
• An Allosteric Mechanism for Inhibiting HIV-1 Integrase with a Small Molecule

  2009cites this paper
• HIV-1 IN inhibitors: 2010 update and perspectives.

  2009cites this paper
• Current and Novel Inhibitors of HIV Protease

  2009cites this paper
• Pharmacophore‐Based Discovery of Small‐Molecule Inhibitors of Protein–Protein Interactions between HIV‐1 Integrase and Cellular Cofactor LEDGF/p75

  2009cites this paper